Skin, Hair & Nails

Prescription skincare uses medications selected by a licensed healthcare provider to address specific skin conditions or concerns. These treatments may contain active ingredients such as tretinoin, azelaic acid, hydroquinone, clindamycin, or other medications that require professional evaluation. The appropriate product depends on your skin concerns, health history, and treatment goals.

Prescription treatments may contain medications or combinations that are not available in ordinary cosmetic products. They can target conditions such as acne, melasma, and rosacea, but they may also require additional precautions or monitoring. Over-the-counter skincare can still play an important role, particularly cleansing, moisturizing, and sun protection.

The Skin, Hair & Nails catalog includes options related to fine lines and texture, melasma and dark spots, acne, rosacea and facial redness, hair and scalp concerns, eyelash growth, and nail care. Specialty skin formulations may also be explored for provider discussion. Not every product is appropriate or available for every patient.

No. You can use the guided skincare questionnaire to identify your main concerns and explore relevant product categories. If you already know which medication interests you, you can browse the treatments directly. Both pathways lead to the appropriate clinical review process.

No single prescription formulation is appropriate for every skin type or condition. Skin sensitivity, pigmentation, existing conditions, medications, pregnancy status, and previous treatment reactions may influence the options a provider considers. Your skincare questionnaire helps collect information for that review.

It depends on the skin concern, active ingredients, and individual response. Some treatments are evaluated over several weeks, while pigmentation problems, nail conditions, and longer-term skin-texture concerns may require months of care. Your provider can explain reasonable expectations for the specific treatment being considered.

Certain prescription retinoids, including tretinoin, have evidence supporting improvement in some fine lines, pigmentation irregularities, and skin-texture concerns. Results vary, and prescription skincare does not eliminate every type of wrinkle or replace all in-office rejuvenation treatments. A provider can help determine whether a topical approach fits your goals.

Tretinoin is a prescription retinoid derived from vitamin A. Retinol is commonly found in over-the-counter skincare and must undergo conversion within the skin to become biologically active. Tretinoin has established uses in acne treatment and certain photoaging concerns, but it may also cause dryness, irritation, and increased sensitivity during treatment.

These are three catalog formulations combining tretinoin, azelaic acid, and niacinamide. They differ in tretinoin concentration: Retinoid Low Strength contains 0.015%, Retinoid Medium Strength contains 0.03%, and Retinoid Higher Strength contains 0.045%, while the other two ingredients remain at their listed concentrations. The formulation names help distinguish the products; they do not automatically establish which one is safest or most appropriate for you.

No. A higher concentration does not automatically produce a better outcome for every patient. The appropriate treatment depends on your skin's tolerance, previous retinoid exposure, specific concerns, and the risk of irritation. A licensed provider determines whether a particular concentration is suitable.

Skin Renewal + Vitamin C is a catalog gel combining niacinamide 4%, tretinoin 0.03%, and ascorbic acid 5%, a form of vitamin C. These ingredients have different roles in skincare, but the particular compounded combination has not necessarily been studied in the same way as its individual ingredients. Its suitability and availability depend on provider and pharmacy review.

Possibly, but sensitivity is an important consideration. Tretinoin-containing products can cause redness, dryness, peeling, and irritation, especially when beginning treatment or combining them with other irritating products. A provider should review your history before selecting a formulation and explaining how it should be used.

Yes. Sun protection remains important for managing photoaging, uneven pigmentation, and many other skin concerns. Some prescription treatments can cause irritation, and unprotected sun exposure may work against your skincare goals. Broad-spectrum sunscreen, protective clothing, and sensible sun habits should remain part of your routine.

Sirolimus Skin Formula is a specialty compounded formulation associated with sirolimus and niacinamide in the pharmacy catalog. It is not a standard, established skin-renewal treatment for routine self-selection, and its exact catalog concentration requires further verification. It should be considered an educational or provider-discussion option unless the formulation and clinical protocol have been specifically approved.

Melasma is a pigmentation condition that commonly produces darker patches on the face. It can be influenced by sun exposure, hormonal factors, and individual susceptibility. Treatment often involves a combination of sun protection and carefully selected topical medications.

These conditions can look similar but have different causes. Melasma often appears as broader or symmetrical patches, sun-related spots develop in response to ultraviolet exposure, and post-inflammatory hyperpigmentation can follow acne or skin irritation. An accurate assessment matters because the most appropriate treatment may differ.

LPWWC's catalog includes Melasma Hydroquinone 4%, 6%, and 8% combination creams and Melasma Hydroquinone-Free gel. The HQ combinations contain hydroquinone, tretinoin, azelaic acid, and hydrocortisone. Melasma Hydroquinone-Free combines niacinamide, tranexamic acid, and tretinoin. The appropriate formulation depends on an individual clinical assessment.

These formulations contain the same four listed active ingredients but different hydroquinone concentrations of 4%, 6%, and 8%. The higher-concentration versions require additional clinical and catalog review and should not be treated as routine upgrades. More hydroquinone does not automatically mean a better or safer result.

Hydroquinone is a medication used in certain prescription treatments for excessive skin pigmentation. It reduces melanin production and may help with appropriately diagnosed pigment conditions. It also carries risks, including irritation and, with inappropriate or prolonged use, a form of potentially persistent skin discoloration called ochronosis.

Melasma Hydroquinone-Free is a catalog gel combining niacinamide 4%, tranexamic acid 4%, and tretinoin 0.03%. It does not contain hydroquinone, but it does contain a prescription retinoid. Its ingredient profile differs from the hydroquinone-containing creams, and a provider should determine whether this particular compounded formulation is appropriate.

Yes. Melasma can be persistent and may recur, particularly when triggering factors such as sun exposure remain. Even when pigmentation improves, ongoing sun protection and an appropriate maintenance plan may be important. Treatment should focus on realistic improvement and long-term management rather than promises of permanent removal.

Sunlight and visible light can contribute to melasma and make discoloration more difficult to manage. Dermatologists commonly recommend broad-spectrum sun protection, with tinted formulations containing iron oxides often considered useful for visible-light protection. Medication alone may not provide satisfactory long-term management without protecting the skin.

Prescription acne treatments may be considered for clogged pores, inflammatory pimples, recurring breakouts, and certain related concerns. The appropriate treatment depends on the type and severity of acne, previous medication use, and the possibility of scarring. Deep, painful, or scarring acne may require a more comprehensive evaluation.

The catalog includes Acne Balance, Acne + Retinoid, Acne Oil Balance, and Acne Multi-Action. These products contain different combinations of ingredients such as azelaic acid, clindamycin, niacinamide, tretinoin, dapsone, and spironolactone. Acne Multi-Action is an additional-review formulation rather than a routine self-selection option.

Acne Balance is a compounded gel containing azelaic acid 5%, clindamycin 1%, niacinamide 2%, and spironolactone 5%. It combines several ingredients with different properties relevant to acne care. A provider must consider the complete combination rather than treating the product as interchangeable with any single ingredient.

Acne + Retinoid is a compounded gel containing clindamycin 1%, niacinamide 4%, and tretinoin 0.02%. Tretinoin is a topical retinoid, while clindamycin is an antibiotic. The provider should review previous treatments, irritation history, and an appropriate antibiotic-resistance management plan.

Acne Oil Balance is a compounded gel containing dapsone 6%, niacinamide 2%, and spironolactone 5%. Dapsone-containing treatments require attention to relevant medication history and blood-related conditions, including known G6PD deficiency or methemoglobinemia. This combination should not be assumed appropriate simply because a patient has acne.

Acne Multi-Action combines clindamycin, dapsone, niacinamide, and tretinoin. Because it contains multiple active ingredients, a provider must consider their combined precautions, previous treatments, and individual safety factors. It is reserved for additional review rather than routine automatic treatment selection.

Some acne treatments contain ingredients that may also be useful in managing certain pigmentation concerns, including retinoids or azelaic acid. However, controlling active acne and treating residual pigmentation are related but different goals. Your provider may recommend addressing ongoing breakouts before focusing on persistent dark marks.

Combining several acne medications can increase irritation or duplicate active ingredients. Products containing topical antibiotics also require appropriate consideration of antibiotic resistance. Tell the reviewing provider about prescription products, retinol, benzoyl peroxide, exfoliating acids, and other skincare treatments you already use.

Rosacea is a chronic inflammatory skin condition that commonly affects the central face. It may involve persistent redness, flushing, visible blood vessels, bumps, or increased skin sensitivity. Some people also experience eye-related symptoms. Treatment depends on the particular features present.

Rosacea can involve flushing, persistent redness, and acne-like bumps, but it does not behave exactly like acne. Other conditions, including contact dermatitis and certain inflammatory disorders, can also produce redness. A correct diagnosis helps avoid using skincare products that may worsen the problem.

LPWWC's catalog includes Rosacea Multi-Care and Rosacea Redness Care. Both are multi-ingredient topical formulations designed around ingredients used in different aspects of rosacea care. Their exact combinations require individualized review, and neither should be regarded as a universal treatment for every form of facial redness.

Rosacea Multi-Care combines azelaic acid 5%, brimonidine 0.25%, ivermectin 1%, metronidazole 1%, and niacinamide 4%. These ingredients have different pharmacologic actions. A provider should consider your symptoms, cardiovascular history, medication use, and previous skin reactions when reviewing this compound.

Rosacea Redness Care is a compounded gel containing ivermectin 1%, niacinamide 2%, and oxymetazoline 0.75%. Oxymetazoline is associated with temporary reduction of persistent facial redness in certain approved formulations, while ivermectin has uses in inflammatory rosacea care. Evidence for an individual ingredient should not automatically be assumed to establish the effectiveness of this specific compound.

Different rosacea medications target different features, including persistent redness and inflammatory bumps. A multi-ingredient formulation may contain ingredients relevant to more than one feature, but its suitability must be evaluated individually. A provider may also recommend a different treatment approach depending on the symptoms.

Eye redness, irritation, dryness, or burning can occur with ocular rosacea, but other eye conditions can cause similar symptoms. Tell your provider about any eye involvement. Significant eye pain, sensitivity to light, or changes in vision warrant prompt evaluation rather than relying on a routine facial skincare questionnaire.

Yes. Bimatoprost 0.03% is an ingredient used in the FDA-approved prescription product Latisse for eyelash hypotrichosis, or inadequate eyelashes. It can increase eyelash length, thickness, and darkness in appropriate patients. A provider must determine whether treatment is suitable.

Both options in the LPWWC catalog are listed as bimatoprost 0.03%, but they are separate commercial products with different package sizes. The catalog lists generic bimatoprost at 5 mL and branded Latisse at 3 mL. Product identity, approved labeling, packaging, and pricing should be confirmed rather than assuming every bimatoprost presentation is interchangeable.

Eyelash changes develop gradually rather than immediately. The approved Latisse clinical program assessed improvement over 16 weeks, although individual responses vary. Continued use may be required to maintain the effect, and lashes generally return toward their original appearance after treatment is discontinued.

Bimatoprost can increase brown pigmentation in the iris, and this change may be permanent. It may also darken eyelid skin, while other possible reactions include eye redness or irritation. These risks should be discussed during clinical review before treatment.

Contact-lens use and prescription eye medications are important details to discuss with the reviewing provider. Bimatoprost can affect eye pressure, and its use alongside certain glaucoma medications requires particular consideration. Follow the exact approved product instructions for contact lenses and application if treatment is prescribed.

The approved Latisse instructions describe application to the upper eyelid margin at the base of the eyelashes, not routine application to the lower eyelashes or eyebrows. Using it outside the directed area can lead to unintended hair growth or other adverse effects. Use the medication only as instructed by the prescribing provider and the specific product labeling.

A fungal infection is one possible cause, but nail trauma, psoriasis, and other conditions can also change nail appearance. Discoloration alone does not confirm a fungal infection. A healthcare professional may need to examine or test the nail to establish the cause.

The catalog includes a compounded nail solution combining terbinafine 2%, itraconazole 1%, and ibuprofen 2%. It is a proposed topical treatment option for clinician consideration when appropriate.

Its inclusion in the catalog does not confirm that any particular nail change is fungal or that this exact combination is an established first-line treatment.

Testing may be appropriate because several conditions resemble fungal nail infections. A clinician may recommend a nail clipping, scraping, or other diagnostic assessment to confirm the cause. This helps avoid using antifungal medication for a problem unrelated to fungus.

Nail improvement is often slow because a healthier-looking nail must grow outward. Toenails may take many months to grow out, even when treatment is effective. The timeline depends on the nail involved, the diagnosis, and the treatment selected.

GHK-Cu is a copper-binding peptide that has attracted interest in skincare research. The LPWWC catalog includes a 0.5% facial serum formulation. Evidence for the specific compounded product's clinical benefits is limited, so it is reserved for additional review rather than presented as a proven wrinkle-reversal or skin-rejuvenation treatment.

Not necessarily. A topical product and an in-office procedure address skin concerns through different approaches and may have different levels of supporting evidence. A serum should not be assumed to replace treatments such as microneedling, IPL, or other services. The best approach depends on the concern and the available evidence.

No. Some products may be FDA-approved commercial medications, while others are custom-compounded formulations. FDA-approved drugs undergo the agency's drug-approval review process; compounded medications do not receive that same premarket approval. The status of each exact product matters, not just whether one of its ingredients appears in an approved medication.

A compounded medication is prepared by a licensed pharmacist or other authorized compounder using ingredients selected for a particular patient's medical needs. Compounding can be useful in certain circumstances, but a compounded product is not itself FDA-approved. Its formulation, quality, suitability, and lawful availability require appropriate professional review.

Side effects depend on the ingredients. Topical retinoids and other active skincare medications can cause dryness, redness, peeling, burning, or irritation. Some products have additional ingredient-specific risks. Review the instructions provided with your prescription and contact your healthcare provider if you develop a concerning reaction.

That depends on the ingredients, but certain products should be avoided during pregnancy, including topical retinoids such as tretinoin. Other medications may require additional review during pregnancy or breastfeeding. Tell your provider if you are pregnant, might be pregnant, are planning pregnancy, or are breastfeeding before starting treatment.

Disclose the ingredient or medication, the type of reaction, and when it occurred. Combination skincare formulations contain multiple active and inactive ingredients, so a provider needs to evaluate the complete product. If you've previously experienced severe swelling, breathing difficulty, or another serious reaction, that history is particularly important.

Some topical medications have ingredient-specific precautions and potential interactions. For example, dapsone-containing products require relevant blood-disorder and medication history, while certain redness-reducing medications may require cardiovascular review. The questionnaire collects information to support a safe and informed provider assessment.

Some treatments can initially cause dryness, irritation, or changes in appearance, but worsening symptoms should not automatically be dismissed as a normal adjustment period. Severe irritation, an unusual rash, swelling, or other concerning changes deserve professional guidance. Your provider can help distinguish an expected reaction from a problem that requires changing treatment.

Possibly, but combining medications can increase the risk of irritation, duplicate ingredients, or create other safety issues. This is especially important with multiple retinoids, exfoliating products, antibiotic-containing formulations, and specialty compounds. Have your complete skincare routine reviewed before combining treatments.

The questionnaire helps you explore skincare categories, identify treatment preferences, and provide information relevant to a provider's review. It uses conditional questions, so you only see follow-up questions that are relevant to your answers. The information you provide does not automatically establish a diagnosis or authorize a prescription.

"I Know What I Want" lets you browse available products and explore a specific formulation directly. "Help Me Choose" starts with questions about your primary skin concern, previous treatment experience, and preferences before showing relevant options. Both pathways lead to the same appropriate clinical-review process.

The Skincare Snapshot organizes the information you've selected into a visual summary and highlights product categories or formulations that may be worth exploring. It may also show important questions to discuss with a provider. These are preference-based exploration results, not automated medical diagnoses or prescribing decisions.

Yes. The comparison tool lets visitors review ingredients, formulation type, package size, and verified medication prices of supported products. Provider-review fees and shipping are shown separately in the order estimate. A comparison can help you understand the differences, but it does not establish that one product is medically superior or suitable for you.

The program is designed as a telehealth-only pathway, with remote clinical review and home shipment when a medication is prescribed and available. The clinic does not offer in-office medication pickup as part of this skincare program. Some concerns may require an additional evaluation that cannot be completed through a routine online request.

The initial program is designed for eligible patients receiving telehealth care while physically located in WY. Your physical location at the time of the encounter matters, and shipping eligibility is reviewed separately. Being a WY resident alone does not guarantee that a particular medication or service is available.

The location of the patient during a telehealth encounter may determine which licensed providers can provide care. The shipping address is used for pharmacy fulfillment when a prescription is authorized. These are separate requirements, which is why the questionnaire may request both.

A licensed provider may request clear photographs, additional history, or other information to help evaluate your concern. Some conditions cannot be reliably assessed through photos alone and may require further examination or testing. Any requested images or medical records should be submitted through the appropriate secure clinical process.

Pricing depends on the selected medication, formulation, package size, pharmacy fulfillment costs, and any applicable provider-review fee. The page is designed to show estimated patient totals where pricing has been verified. Your final amount should be confirmed through the actual available checkout or treatment-request process.

The provider-review fee is $25 for one medication or $35 total for two or more distinct medications in an order. It is added once per order, not once per product. Browsing treatments or using the educational questionnaire does not charge a fee.

Medication prices are displayed separately from the provider-review fee and $15 standard shipping. The order estimate shows these charges before any payment can be authorized. An estimated price is not a guarantee of product availability or fulfillment.

No. Visitors can explore the skincare pages and educational content without a paid membership. The treatments are organized within LPWWC's Membership navigation, but that does not by itself establish a paid-membership requirement for viewing the information. Any future membership-specific benefits or pricing should be explained separately when offered.

No. Product selection is a request for consideration, not a prescription. A licensed provider reviews the information and determines whether the requested treatment is appropriate. The provider may request additional information, recommend a different approach, or decide not to prescribe.

You can explore formulations, build a selection, and review an estimate on this page. Online payment and secure clinical submission are currently unavailable. Exploring a formulation or reviewing your selections does not create an order, charge a payment method, or authorize medication.

The next step depends on the provider's assessment and the treatment workflow available at that time. A provider may approve an appropriate prescription, request additional information, require further evaluation, or recommend against the selected medication. If a prescription is authorized and available for fulfillment, the pharmacy can arrange home shipment through the established process.

Signature Formulas are featured prescription options available for provider-guided review. Specialty Formulas are specialized options that require additional provider evaluation. Your provider determines whether any treatment is appropriate for you.

Scalp treatments are applied directly to the scalp. Oral medications are swallowed and can affect the body more broadly. Some formulas contain one active ingredient, while others combine several. Neither option is automatically better. The appropriate choice depends on the cause of hair loss, medical history, and provider evaluation.

Not necessarily. The label counts ingredients; it does not prove that the combination works better or is right for you. Compare the specific ingredients and discuss them with the care team.

Depending on the product, formulas may contain minoxidil, finasteride, dutasteride, tretinoin, ketoconazole, azelaic acid, or GHK-Cu. Every card lists the exact ingredients and strengths.

Hair grows slowly, so visible changes usually take months rather than weeks. Some people first notice less shedding. Others may see changes in hair thickness over time. Results vary by treatment and the cause of hair loss. Some people may not respond. Ongoing treatment may be needed to maintain benefits.

Hair can thin for several reasons, including family history, hormones, age, stress, illness, certain medications, and nutritional deficiencies. Some people notice gradual thinning, while others experience sudden shedding or patches of hair loss. Finding the cause matters because different types of hair loss may need different treatments.

Yes. LPWWC offers information about hair and scalp treatments for different patients. However, not every medication is appropriate for everyone. Certain ingredients have important pregnancy-related restrictions, and some products are intended for specific patient groups. A provider reviews these factors before determining which options, if any, are appropriate.

Not necessarily. You can start by exploring your concerns through our guided questionnaire. However, the cause of hair loss should be considered before treatment. Sudden shedding, painful scalp symptoms, or patchy hair loss may need a separate medical evaluation rather than routine hair-growth medication.

GHK-Cu Scalp Care is a specialty scalp solution containing GHK-Cu, also known as a copper peptide. It is included in our catalog for patients interested in learning about specialty scalp formulations. Research into its usefulness for hair growth is still limited, so it should not be presented as a proven hair-regrowth treatment. Additional provider review is required.

Hair Growth Duo is a scalp solution that combines minoxidil 5% and azelaic acid 12.5%. Minoxidil is used in hair-loss treatments, while azelaic acid is an additional ingredient in this compounded formula. This combination is not the same as an FDA-approved minoxidil product. A provider can help explain its ingredients and whether a compounded option is appropriate.

Hair Growth + Dutasteride is a specialty scalp solution containing dutasteride 1%. Dutasteride affects the hormone pathway involved in certain forms of pattern hair loss. This topical formulation is not an FDA-approved hair-loss product. Because of its medication-specific risks and restrictions, it requires additional provider review.

Hair Growth 5-in-1 is a compounded scalp solution containing five active ingredients: minoxidil, dutasteride, finasteride, tretinoin, and ketoconazole. These ingredients have different purposes, and combining more ingredients does not automatically mean better results. This is a specialty formulation requiring additional review of medical history, potential side effects, and medication suitability.

This specialty scalp solution combines minoxidil, dutasteride, and tretinoin. Minoxidil is used in hair-loss treatment, dutasteride affects a hormone pathway related to pattern hair loss, and tretinoin is a retinoid. The combination may cause scalp irritation and has additional medication-related precautions. A provider must determine whether it is appropriate.

This compounded scalp solution contains minoxidil, finasteride, and ketoconazole. Minoxidil is used to support hair growth, finasteride affects a hormone pathway involved in pattern hair loss, and ketoconazole is an antifungal ingredient. The combination requires individual review and should not be treated as automatically suitable for everyone.

This specialty scalp formula combines minoxidil, finasteride, and tretinoin. The ingredients serve different purposes, including hair-loss treatment and effects on the scalp and skin. Because the formulation contains finasteride and a retinoid, pregnancy-related restrictions, irritation, and other precautions are important parts of provider review.

Hair Growth 4-in-1 combines minoxidil, azelaic acid, finasteride, and ketoconazole in one scalp solution. It offers a different ingredient combination from Hair Growth Duo and the other specialty scalp formulas. Four ingredients do not necessarily make it stronger or more effective. Its use depends on individual clinical review.

Finasteride is a prescription medication that lowers the production of dihydrotestosterone, or DHT, a hormone involved in male pattern hair loss. Finasteride 1 mg is FDA-approved for male pattern hair loss. Other strengths or uses may have different indications. Side effects and pregnancy-related restrictions make provider review important.

Dutasteride is a prescription medication that also lowers DHT. It is FDA-approved for certain prostate conditions, not hair loss. Hair-loss use is therefore off-label. Dutasteride may affect sexual function and has important pregnancy-related restrictions. It is not interchangeable with finasteride without a provider’s evaluation.

Minoxidil is available as an oral prescription medication originally developed to treat severe high blood pressure. Some providers use lower doses off-label for certain hair-loss conditions. Oral minoxidil can affect blood pressure, heart rate, and fluid retention. It requires careful medical review and is different from applying minoxidil directly to the scalp.

This compounded capsule combines biotin and minoxidil. Minoxidil is used in some hair-loss treatment plans. Biotin is a vitamin, but taking extra biotin has not been shown to improve hair growth in everyone. The formulation is not FDA-approved as a combined product and requires provider review, particularly because it contains oral minoxidil.

This compounded capsule contains biotin, finasteride, and minoxidil. Finasteride affects a hormone pathway involved in pattern hair loss, while minoxidil has a different mechanism. The formulation combines medications with different side effects and restrictions. It is not appropriate for everyone and requires additional provider evaluation.

This compounded capsule contains biotin, minoxidil, and spironolactone. Spironolactone is sometimes prescribed off-label for certain forms of hair loss, especially when hormones play a role. Because it can affect blood pressure and potassium levels, and minoxidil has cardiovascular effects, this combination requires careful provider review.

Oral medications can affect more than just your hair. Depending on the ingredient, a provider may need to review your blood pressure, heart health, kidney function, other medications, pregnancy plans, or other health information. Additional review helps determine whether a treatment is appropriate. Selecting a medication online does not guarantee a prescription.

Oral minoxidil may cause unwanted hair growth, swelling, fluid retention, dizziness, or a faster heartbeat. Rare but serious heart-related complications are also possible. Tell your provider about any heart, blood pressure, or kidney problems before considering this medication. Seek prompt medical attention for chest pain, shortness of breath, fainting, or significant swelling.

Other oral hair medications have different risks, including changes in sexual function and medication interactions. A clinician reviews the risks of each ingredient individually.

Both medications reduce DHT, a hormone associated with pattern hair loss. They work on this pathway differently and do not have identical approved uses, duration of action, or safety considerations. Finasteride 1 mg is approved for male pattern hair loss; dutasteride is not FDA-approved for hair loss. A provider determines whether either is appropriate.

Spironolactone is a prescription medication that affects certain hormone pathways and is sometimes used off-label for female pattern hair loss. It can also affect blood pressure and potassium. It is not appropriate during pregnancy, and some patients need laboratory monitoring. Its use depends on individual medical history and provider evaluation.

Yes. Biotin can interfere with some laboratory tests and produce inaccurate results, including certain heart-related and hormone tests. Tell your medical team and laboratory about any supplement or medication containing biotin before testing. Do not assume more biotin will improve hair growth unless a deficiency or another reason for supplementation has been identified.

Some hair-loss medications, including finasteride and dutasteride, can pose serious risks during pregnancy. Other oral and topical hair treatments also require pregnancy and breastfeeding precautions. Tell your provider if you are pregnant, breastfeeding, may become pregnant, or are planning pregnancy. Do not start or combine these medications without appropriate medical guidance.

NAD+ Skin Cream is a specialty topical formula containing NAD+ 10%. NAD+ is a molecule involved in normal cell processes. Its use in topical skincare is still being studied, and clear clinical benefits for skin renewal have not been established. This compounded cream is not FDA-approved and requires additional provider review.

Skin Renewal + Hormone Blend is a specialty formula that includes skin-focused ingredients along with estriol and progesterone. Because it contains hormones, it is not a routine non-hormonal skincare treatment. It may be shown for educational comparison, but any potential availability or use requires a separately approved clinical pathway and individualized provider review.

No. Both contain GHK-Cu, a copper peptide, but they are listed as separate formulations intended for different application areas. Their concentrations, containers, and intended uses may differ. A product intended for the scalp should not automatically be used on the face, and a facial product should not automatically be used on the scalp.

Some formulas are listed to help patients understand the available ingredients and treatment categories, even when routine online selection is not offered. A formula may need further pharmacy verification, clinical review, or a different treatment pathway. The product card should clearly show whether it is currently selectable, requires additional review, or is for education only.

It depends on the ingredients. Some combinations may increase irritation or create other concerns, especially when a product contains retinoids, hormones, or multiple active ingredients. Tell your provider about prescription creams, over-the-counter products, and recent skin treatments before combining them. Specialty formulas should not be assumed compatible with an existing routine.